RADIOGRAPHIC SEMIOTICS OF CONGENITAL HEART DEFECTS COMPLICATED BY HIGH PULMONARY HYPERTENSION: DIAGNOSTIC CRITERIA AND CLINICAL SIGNIFICANCE
Abstract
Congenital heart defects (CHD) occupy one of the leading places among congenital anomalies of development and are a significant cause of infant mortality and disability in the child population worldwide: according to the World Health Organization, the incidence of CHD is 8–12 cases per 1000 live births, and about 1.35 million children with this pathology are born annually in the world [1, 2]. Among all forms of CHD, defects are of particular clinical importance, accompanied by blood discharge from left to right, such as ventricular septal defect, atrial septal defect, patent ductus arteriosus, and atrioventricular canal, which together account for up to 40–50% of all CHD and, in the absence of timely surgical correction, are naturally complicated by the development of pulmonary arterial hypertension (PAH) [3, 4]. According to large epidemiological studies, CHD-associated PAH is detected in 1.6–12.5 per million population, while in patients with uncorrected malformations with pulmonary hypervolemia, pulmonary hypertension is formed in 30–50% of cases within the first two years of life [5, 6]. An extreme and irreversible manifestation of this complication is Eisenmenger syndrome, in which the pressure in the pulmonary artery reaches the systemic level, blood discharge becomes right-left and surgical correction of the defect is impossible; The survival rate of such patients is significantly reduced, and the median life expectancy does not exceed 40–50 years [7, 8].
References
1. van der Linde D., Konings E.E., Slager M.A. et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis // Journal of the American College of Cardiology. — 2011. — Vol. 58, № 21. — P. 2241–2247. DOI: 10.1016/j.jacc.2011.08.025
2. Zimmermann N., Haas N.A., Photiadis J. et al. Congenital heart disease: epidemiology, diagnosis and treatment // Deutsches Ärzteblatt International. — 2023. — Vol. 120, № 18. — P. 308–317. DOI: 10.3238/arztebl.m2023.0063
3. Lammers A.E., Apitz C., Zartner P. et al. Diagnostics, monitoring and outpatient care in children with suspected pulmonary arterial hypertension // Cardiology in the Young. — 2023. — Vol. 33, № 1. — P. 1–17. DOI: 10.1017/S1047951122003560
4. Bokeria L.A., Tumanyan M.R., Chechneva V.V. Congenital heart defects with enrichment of the small circle of blood circulation: modern approaches to diagnosis and treatment. — 2021. — T. 26, No 3. — S. 142–151. DOI: 10.18821/1560-9502-2021-26-3-142-151
5. Simonneau G., Montani D., Celermajer D.S. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension // European Respiratory Journal. — 2019. — Vol. 53, № 1. — P. 1801913. DOI: 10.1183/13993003.01913-2018
6. Hansmann G., Koestenberger M., Alastalo T.P. et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension // Heart. — 2019. — Vol. 105, Suppl. 1. — P. S1–S80. DOI: 10.1136/heartjnl-2019-315840
7. Diller G.P., Kempny A., Inuzuka R. et al. Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience // Heart. — 2014. — Vol. 100, № 17. — P. 1366–1372. DOI: 10.1136/heartjnl-2014-305690
8. Gatzoulis M.A., Beghetti M., Landzberg M.J., Galiè N. Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions // International Journal of Cardiology. — 2014. — Vol. 177, № 2. — P. 340–347. DOI: 10.1016/j.ijcard.2014.09.024
9. Geva T., Martins J.D., Wald R.M. Atrial septal defects // *The Lancet.* — 2014. — Vol. 383, № 9932. — P. 1921–1932. DOI: 10.1016/S0140-6736(13)62145-5
10. Kellenberger C.J. Chest radiography in paediatric patients with congenital heart disease // Pediatric Radiology. — 2021. — Vol. 51, № 5. — P. 726–740. DOI: 10.1007/s00247-020-04898-3
11. Humbert M., Kovacs G., Hoeper M.M. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension // European Heart Journal. — 2022. — Vol. 43, № 38. — P. 3618–3731. DOI: 10.1093/eurheartj/ehac237
12. Dimopoulos K., Wort S.J., Gatzoulis M.A. Pulmonary hypertension related to congenital heart disease: a call for action // European Heart Journal — 2014. — Vol. 35, № 11. — P. 691–700. DOI: 10.1093/eurheartj/eht437
